List of Excipients in API DORZOLAMIDE HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing DORZOLAMIDE HYDROCHLORIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme LLC | TRUSOPT | dorzolamide hydrochloride | 0006-3519 | BENZALKONIUM CHLORIDE | |
| Merck Sharp & Dohme LLC | TRUSOPT | dorzolamide hydrochloride | 0006-3519 | HYDROXYETHYL CELLULOSE | |
| Merck Sharp & Dohme LLC | TRUSOPT | dorzolamide hydrochloride | 0006-3519 | MANNITOL | |
| Merck Sharp & Dohme LLC | TRUSOPT | dorzolamide hydrochloride | 0006-3519 | SODIUM HYDROXIDE | |
| Merck Sharp & Dohme LLC | TRUSOPT | dorzolamide hydrochloride | 0006-3519 | TRISODIUM CITRATE DIHYDRATE | |
| Merck Sharp & Dohme LLC | TRUSOPT | dorzolamide hydrochloride | 0006-3519 | WATER | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing DORZOLAMIDE HYDROCHLORIDE
Detailed excipient profiles for DORZOLAMIDE HYDROCHLORIDE
Excipient focus: AQUA
DORZOLAMIDE HYDROCHLORIDE drug variants containing AQUA
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | dorzolamide hydrochloride and timolol maleate | 50090-6371 |
| >Company | >Ingredient | >NDC |
DORZOLAMIDE HYDROCHLORIDE drug variants not containing AQUA
Excipient focus: BENZALKONIUM CHLORIDE
DORZOLAMIDE HYDROCHLORIDE drug variants containing BENZALKONIUM CHLORIDE
DORZOLAMIDE HYDROCHLORIDE drug variants not containing BENZALKONIUM CHLORIDE
Excipient focus: HYDROXYETHYL CELLULOSE
DORZOLAMIDE HYDROCHLORIDE drug variants containing HYDROXYETHYL CELLULOSE
DORZOLAMIDE HYDROCHLORIDE drug variants not containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
DORZOLAMIDE HYDROCHLORIDE drug variants containing MANNITOL
DORZOLAMIDE HYDROCHLORIDE drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: NITROGEN
DORZOLAMIDE HYDROCHLORIDE drug variants containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| Florida Pharmaceutical Products LLC | dorzolamide hydrochloride ophthalmic | 71921-400 |
| >Company | >Ingredient | >NDC |
DORZOLAMIDE HYDROCHLORIDE drug variants not containing NITROGEN
Excipient focus: SODIUM CITRATE
DORZOLAMIDE HYDROCHLORIDE drug variants containing SODIUM CITRATE
DORZOLAMIDE HYDROCHLORIDE drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
DORZOLAMIDE HYDROCHLORIDE drug variants containing SODIUM HYDROXIDE
DORZOLAMIDE HYDROCHLORIDE drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
DORZOLAMIDE HYDROCHLORIDE drug variants containing TRISODIUM CITRATE DIHYDRATE
DORZOLAMIDE HYDROCHLORIDE drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
DORZOLAMIDE HYDROCHLORIDE drug variants containing WATER
DORZOLAMIDE HYDROCHLORIDE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | dorzolamide hydrochloride and timolol maleate | 50090-6371 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch